Nanoparticle enhanced blue light therapy
Files
(Published version)
Date
2022
Authors
Akasov, R.
Khaydukov, E.V.
Yamada, M.
Zvyagin, A.V.
Leelahavanichkul, A.
Leanse, L.G.
Dai, T.
Prow, T.
Editors
Advisors
Journal Title
Journal ISSN
Volume Title
Type:
Journal article
Citation
Advanced Drug Delivery Reviews, 2022; 184(article no. 114198):1-17
Statement of Responsibility
Conference Name
Abstract
As antimicrobial resistance continues to compromise the therapeutic efficacy of countless antibiotics, the significant risk this poses to the global population is without question and should be considered emergent. Antimicrobial resistance can be deadly, specifically in terms of case numbers and disease prognosis. The United States Centers for Disease Control and Prevention released a report stating that in the U.S., two million people suffer from severe infections that are highly resistant to conventional treatment regimens.
School/Discipline
Dissertation Note
Provenance
Description
Access Status
Rights
Copyright 2022 The Authors